A Deacetylase-Deficient SIRT1 Variant Opposes Full-Length SIRT1 in Regulating Tumor Suppressor P53 and Governs Expression of Cancer-Related Genes

Molecular and Cellular Biology - United States
doi 10.1128/mcb.06448-11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Developmental Defects and P53 Hyperacetylation in Sir2 Homolog (SIRT1)-deficient Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

FoxO1 Mediates an Autofeedback Loop Regulating SIRT1 Expression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Immunomodulation and Mechanism of Protein Deacetylase SIRT1

Immunology Studies
2013English

SIRT1 Inactivation Evokes Antitumor Activities in NSCLC Through the Tumor Suppressor P27

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2014English

Relative Transcription Expression Level of SIRT1, SIRT2 and SIRT3 in Correlation to the Expression of a Set of Selected Cancer Related Genes in Human Breast Cancer

OnLine Journal of Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2018English

MicroRNA‑486‑5p Functions as a Tumor Suppressor of Proliferation and Cancer Stem‑like Cell Properties by Targeting Sirt1 in Liver Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

P53 and Sirt1: Routes of Metabolism and Genome Stability

Biochemical Pharmacology
BiochemistryPharmacology
2014English

Post-Translational Regulation Contributes to the Loss of LKB1 Expression Through SIRT1 Deacetylase in Osteosarcomas

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy